Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Channel unblocking refers to the physiological or pharmacological process of removing a blocking agent from the pore of an ion channel, thereby restoring its ability to conduct ions. This term does not describe a specific protein or receptor but rather a functional transition or mechanism of action observed in various ion channels. A prominent biological example is the voltage-dependent magnesium (Mg2+) block of the N-methyl-D-aspartate (NMDA) receptor; depolarization of the postsynaptic membrane expels the Mg2+ ion, 'unblocking' the channel and allowing calcium influx, which is a fundamental requirement for synaptic plasticity and memory formation (Nowak et al., 1984). In clinical settings, channel unblocking is central to the reversal of neuromuscular blockade, where agents like Sugammadex act by encapsulating steroidal muscle relaxants, effectively 'unblocking' nicotinic acetylcholine receptors to restore muscle function (Naguid, 2007). Additionally, the therapeutic profile of drugs like memantine is defined by their 'unblocking' kinetics, where a relatively rapid rate of leaving the channel pore allows for the preservation of normal neurotransmission while preventing pathological overactivation (Parsons et al., 1999). Because it describes a functional event rather than a discrete biological entity, 'Channel unblocking' is considered a mechanism of action rather than a therapeutic target molecule.
Channel unblocking is a mechanism where an obstructing molecule or ion is removed from the pore of an ion channel, thereby restoring its conductive state and allowing the flow of ions across the cell membrane.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Channel unblocking.